Efficacy of axitinib in patients with metastatic renal cell carcinoma previously treated with both VEGFR-TKI and mTORI.

Renal Cell ◽

Lenvatinib plus pembrolizumab in patients with either treatment-naive or previously treated metastatic renal cell carcinoma (Study 111/KEYNOTE-146): a phase 1b/2 study

The Lancet Oncology ◽

10.1016/s1470-2045(21)00241-2 ◽

2021 ◽

Author(s):

Chung-Han Lee ◽

Amishi Yogesh Shah ◽

Drew Rasco ◽

Arpit Rao ◽

Matthew H Taylor ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Renal Cell ◽

Treatment Naïve ◽

Previously Treated ◽

Phase 1B

How does targeted immunotherapy compare with standard targeted therapy for people with previously treated metastatic renal cell carcinoma?

Cochrane Clinical Answers ◽

10.1002/cca.2629 ◽

2019 ◽

Author(s):

Jane Burch ◽

Gustavo Villalobos

Keyword(s):

Renal Cell Carcinoma ◽

Targeted Therapy ◽

Cell Carcinoma ◽

Renal Cell ◽

Previously Treated ◽

Targeted Immunotherapy

Clinical Activity and Safety of Anti-Programmed Death-1 (PD-1) (BMS-936558/MDX-1106/ONO-4538) in Patients (PTS) with Previously Treated, Metastatic Renal Cell Carcinoma (MRCC)

Annals of Oncology ◽

10.1016/s0923-7534(20)33350-0 ◽

2012 ◽

Vol 23 ◽

pp. ix258-ix259 ◽

Cited By ~ 2

Author(s):

D.F. McDermott ◽

C.G. Drake ◽

M. Sznol ◽

T.K. Choueiri ◽

J.D. Powderly ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Renal Cell ◽

Clinical Activity ◽

Programmed Death ◽

Programmed Death 1 ◽

Efficacy and Safety of Sequential Use of Everolimus in Patients With Metastatic Renal Cell Carcinoma Previously Treated With Bevacizumab With or Without Interferon Therapy: Results From the European AVATOR Study

Clinical Genitourinary Cancer ◽

10.1016/j.clgc.2014.09.005 ◽

2015 ◽

Vol 13 (3) ◽

pp. 231-238 ◽

Cited By ~ 4

Author(s):

Antoine Thiery-Vuillemin ◽

Christine Theodore ◽

Lutz Jacobasch ◽

Jörg Schmitz ◽

Christos Papandreou ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Renal Cell ◽

Interferon Therapy ◽

Efficacy And Safety ◽

Pazopanib in patients with metastatic renal cell carcinoma previously treated with sunitinib or bevacizumab: A Sarah Cannon Research Institute phase II trial.

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.4659 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. 4659-4659 ◽

Cited By ~ 3

Author(s):

J. A. Reeves ◽

D. R. Spigel ◽

D. B. Daniel ◽

E. K. Friedman ◽

H. A. Burris ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Renal Cell ◽

Phase Ii Trial ◽

Previously Treated ◽

Research Institute

A Randomized Phase II Study of AGS‐16C3F Versus Axitinib in Previously Treated Patients with Metastatic Renal Cell Carcinoma

The Oncologist ◽

10.1002/onco.13628 ◽

2020 ◽

Author(s):

Christian Kollmannsberger ◽

Toni K. Choueiri ◽

Daniel Y.C. Heng ◽

Saby George ◽

Fei Jie ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Renal Cell ◽

Phase Ii Study ◽

Randomized Phase Ii ◽

Previously Treated Patients ◽

Immunomodulatory activity of nivolumab in previously treated and untreated metastatic renal cell carcinoma (mRCC): Biomarker-based results from a randomized clinical trial.

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.5012 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. 5012-5012 ◽

Cited By ~ 12

Author(s):

Toni K. Choueiri ◽

Mayer N. Fishman ◽

Bernard J. Escudier ◽

Jenny J. Kim ◽

Harriet M. Kluger ◽

...

Keyword(s):

Clinical Trial ◽

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Randomized Clinical Trial ◽

Renal Cell ◽

Immunomodulatory Activity ◽

Phase II escalation study of sorafenib in patients with metastatic renal cell carcinoma who have been previously treated with anti-angiogenic treatment

BJU International ◽

10.1111/j.1464-410x.2011.10421.x ◽

2011 ◽

Vol 109 (2) ◽

pp. 200-206 ◽

Cited By ~ 23

Author(s):

Andrea Mancuso ◽

Eugenio Donato Di Paola ◽

Alvaro Leone ◽

Alfonso Catalano ◽

Fabio Calabrò ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Renal Cell ◽

Remarkable antitumor effect of nivolumab in a patient with metastatic renal cell carcinoma previously treated with a peptide‐based vaccine

IJU Case Reports ◽

10.1002/iju5.12139 ◽

2020 ◽

Vol 3 (2) ◽

pp. 44-48

Author(s):

Ryoma Kurahashi ◽

Takanobu Motoshima ◽

Yumi Fukushima ◽

Yoji Murakami ◽

Junji Yatsuda ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Renal Cell ◽

Antitumor Effect ◽

Evaluation of The Clinical Effectiveness of Axitinib, Cabozantinib, Everolimus, Nivolumab, Sunitinib And Best Supportive Care (BSC) In Previously Treated Advanced or Metastatic Renal Cell Carcinoma (AMRCC): A Systematic Review And Mixed-Treatment Comparision (MTC)

Value in Health ◽

10.1016/j.jval.2017.08.105 ◽

2017 ◽

Vol 20 (9) ◽

pp. A415

Author(s):

SJ Edwards ◽

V Wakefield ◽

P Cain ◽

C Karner ◽

K Kew ◽

...

Keyword(s):

Systematic Review ◽

Renal Cell Carcinoma ◽

Supportive Care ◽

Cell Carcinoma ◽

Renal Cell ◽

Clinical Effectiveness ◽

Best Supportive Care ◽

Mixed Treatment ◽